Postprandial symptoms 30 minutes after a maximally tolerated volume of Ensure
| Symptom scores | Placebo group | Octreotide 30 μg group | Octreotide 100 μg group |
|---|---|---|---|
| Data are median scores (interquartile range). Maximum aggregate score=400; maximum individual score=100. | |||
| *p=0.029, **p<0.05 versus placebo (ANOVA on ranks with Dunn’s test). | |||
| †p=0.10 (ANOVA on ranks). | |||
| ‡p=0.085 (ANOVA on ranks). | |||
| Aggregate | 178 (152–219) | 179 (179–227) | 127 (75–250) |
| Fullness* | 84 (71–91) | 70 (60–83) | 65 (33–78)** |
| Nausea† | 40 (15–58) | 14 (0–30) | 14 (5–56) |
| Bloating‡ | 57 (45–74) | 68 (49–81) | 40 (26–64) |
| Pain | 11 (2–28) | 14 (1–35) | 4 (1–46) |